Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Enterohaemorrhagic Escherichia coli

Y Takeda1

  • 1Research Institute, International Medical Center of Japan, Tokyo, Japan.

World Health Statistics Quarterly. Rapport Trimestriel De Statistiques Sanitaires Mondiales
|January 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Sensitivity test for anti-tumor agents-3. MTT assay and its clinical effect].

Gan to kagaku ryoho. Cancer & chemotherapy·1992
Same author

Detection of the thermostable direct hemolysin gene (tdh) and the thermostable direct hemolysin-related hemolysin gene (trh) of Vibrio parahaemolyticus by polymerase chain reaction.

Molecular and cellular probes·1992
Same author

Non-isotopic microtitre plate-based assay for detecting products of polymerase chain reaction amplification: application to detection of the tdh gene of Vibrio parahaemolyticus.

Molecular and cellular probes·1992
Same author

[Development of method for measurement of pulsatile change in arterial diameter in the fetus].

Nihon Sanka Fujinka Gakkai zasshi·1992
Same author

[Enteroadherent Escherichia coli exhibiting localized pattern of adherence among infants with diarrhoea in Brazil--incidence and prevalence of serotypes].

Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases·1992
Same author

[Japanese clinical statistical data of patients with Escherichia coli diarrhea].

Nihon rinsho. Japanese journal of clinical medicine·1992
Same journal

Reflections on health in development and human rights.

World health statistics quarterly. Rapport trimestriel de statistiques sanitaires mondiales·1998
Same journal

Develop and strengthen public health law.

World health statistics quarterly. Rapport trimestriel de statistiques sanitaires mondiales·1998
Same journal

Intersectoral action for health: a cornerstone for health for all in the 21st century.

World health statistics quarterly. Rapport trimestriel de statistiques sanitaires mondiales·1998
Same journal

Partnerships for health in the 21st century.

World health statistics quarterly. Rapport trimestriel de statistiques sanitaires mondiales·1998
Same journal

Targets for health for all in the 21st century.

World health statistics quarterly. Rapport trimestriel de statistiques sanitaires mondiales·1998
Same journal

Essential public health functions--their place in the health-for-all policy for the 21st century.

World health statistics quarterly. Rapport trimestriel de statistiques sanitaires mondiales·1998
See all related articles

Enterohaemorrhagic Escherichia coli produces Shiga toxins that inhibit protein synthesis. This article reviews E. coli O157:H7 outbreaks and discusses potential vaccine development.

Area of Science:

  • Microbiology
  • Toxicology
  • Public Health

Background:

  • Enterohaemorrhagic Escherichia coli (EHEC) produces Shiga toxins, leading to severe gastrointestinal and systemic illnesses.
  • Shiga toxins function as RNA N-glycosidases, inhibiting eukaryotic protein synthesis by targeting ribosomal function.
  • The 1996 Japanese E. coli O157:H7 outbreaks highlighted significant public health challenges and difficulties in identifying food vectors.

Purpose of the Study:

  • To review the mechanism of Shiga toxin action.
  • To discuss the epidemiology of E. coli O157:H7 outbreaks, particularly the 1996 Japanese epidemic.
  • To explore the potential for developing a candidate vaccine against EHEC.

Main Methods:

  • Literature review of Shiga toxin mechanism of action.

Related Experiment Videos

  • Analysis of reported E. coli O157:H7 outbreaks and case data.
  • Discussion of vaccine development strategies.

    • Main Results:

    • Shiga toxins inhibit protein synthesis via RNA N-glycosidase activity.
    • The 1996 Japanese E. coli O157:H7 outbreaks involved approximately 8400 patients, with unidentified food sources in most cases.
    • The feasibility of developing a candidate vaccine is considered.

    Conclusions:

    • Understanding Shiga toxin's molecular mechanism is crucial for combating EHEC infections.
    • Effective outbreak investigation and control remain challenging, necessitating further research into transmission routes.
    • Vaccine development offers a promising avenue for preventing EHEC-related diseases.